Home > Healthcare > Medical Devices > Diagnostic Devices > Fecal Occult Testing Market

Fecal Occult Testing Market Share

Report ID: GMI6513
Published Date: Aug 2023
Report Format: PDF

Download Free Sample

Fecal Occult Testing Market Share

Some of the eminent market participants operating in the fecal occult testing market include

HUMASIS.COM
CTK Biotech, Inc.
Biopanda Reagents Ltd
Biohit Oyj
CERTEST BIOTEC
Cenogenics Corporation
Alfa Scientific Designs, Inc.
Siemens Healthcare GmbH
Jant Pharmacal Corporation.
Quidel Corporation
Wondfo

These market players are undertaking several growth strategies including partnerships, collaborations, acquisitions & mergers, and new product development & launches to strengthen their product portfolio as well as gain a competitive edge over others.

Authors: Mariam Faizullabhoy , Pratiksha Kamthe

Frequently Asked Questions (FAQ) :

Fecal occult testing industry size reached USD 1 billion in 2022 and will witness 7.3% CAGR through 2032 due to the rising incidence of rectal and colon cancer worldwide.

The guaiac FOB stool test segment garnered USD 381.3 million in the fecal occult testing industry in 2022 on account of its established reputation in medical practice and historical integration into colorectal cancer screening programs.

U.S. fecal occult testing industry crossed USD 353.1 million in 2022 and is projected to expand significantly through 2032 owing to the highly advanced and well-established healthcare infrastructure in the region.

HUMASIS.COM, CTK Biotech, Inc., Biopanda Reagents Ltd, Biohit Oyj, CERTEST BIOTEC, Cenogenics Corporation, Alfa Scientific Designs, Inc., Siemens Healthcare GmbH, Jant Pharmacal Corporation., Quidel Corporation, and Wondfo are some of the fecal occult testing companies worldwide.